136 related articles for article (PubMed ID: 18221114)
1. Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases.
Vecchione L; Gargiul E; Borgiani P; Predazzi I; Mango R; Romeo F; Magnani M; Novelli G
Recent Pat Cardiovasc Drug Discov; 2007 Jun; 2(2):147-51. PubMed ID: 18221114
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction.
Mango R; Biocca S; del Vecchio F; Clementi F; Sangiuolo F; Amati F; Filareto A; Grelli S; Spitalieri P; Filesi I; Favalli C; Lauro R; Mehta JL; Romeo F; Novelli G
Circ Res; 2005 Jul; 97(2):152-8. PubMed ID: 15976314
[TBL] [Abstract][Full Text] [Related]
3. LOX-1/LOXIN: the yin/yang of atheroscleorosis.
Mango R; Predazzi IM; Romeo F; Novelli G
Cardiovasc Drugs Ther; 2011 Oct; 25(5):489-94. PubMed ID: 21904818
[TBL] [Abstract][Full Text] [Related]
4. The human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding.
Morini E; Rizzacasa B; Pucci S; Polidoro C; Ferrè F; Caporossi D; Helmer Citterich M; Novelli G; Amati F
J Cell Mol Med; 2016 Jan; 20(1):181-7. PubMed ID: 26542080
[TBL] [Abstract][Full Text] [Related]
5. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.
Biocca S; Filesi I; Mango R; Maggiore L; Baldini F; Vecchione L; Viola A; Citro G; Federici G; Romeo F; Novelli G
J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942
[TBL] [Abstract][Full Text] [Related]
6. LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.
Rizzacasa B; Morini E; Pucci S; Murdocca M; Novelli G; Amati F
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146073
[TBL] [Abstract][Full Text] [Related]
7. OLR1 and Loxin Expression in PBMCs of Women with a History of Unexplained Recurrent Miscarriage: A Pilot Study.
Bruno V; Rizzacasa B; Pietropolli A; Capogna MV; Massoud R; Ticconi C; Piccione E; Cortese C; Novelli G; Amati F
Genet Test Mol Biomarkers; 2017 Jun; 21(6):363-372. PubMed ID: 28409654
[TBL] [Abstract][Full Text] [Related]
8. IVS4-14 A/G and IVS4-73 C/T polymorphisms in OLR1 gene in patients with ischemic cerebrovascular diseases.
Vietri MT; Molinari AM; Boggia M; Parisi M; Cioffi M
Genet Test Mol Biomarkers; 2010 Feb; 14(1):9-11. PubMed ID: 19929426
[TBL] [Abstract][Full Text] [Related]
9. Association of LOXIN, a new functional splicing isoform of the OLR1 gene, with severity and prognostic localization of critical coronary artery stenoses.
Cappelletti A; Zanussi M; Mazzavillani M; Magni V; Calori G; Godino C; Ferrari M; Margonato A
J Cardiovasc Med (Hagerstown); 2014 May; 15(5):391-6. PubMed ID: 24743687
[TBL] [Abstract][Full Text] [Related]
10. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.
Knowles JW; Assimes TL; Boerwinkle E; Fortmann SP; Go A; Grove ML; Hlatky M; Iribarren C; Li J; Myers R; Risch N; Sidney S; Southwick A; Volcik KA; Quertermous T
BMC Med Genet; 2008 Apr; 9():23. PubMed ID: 18384690
[TBL] [Abstract][Full Text] [Related]
11. Association of OLR1 gene polymorphisms with the risk of coronary artery disease: A systematic review and meta-analysis.
Salehipour P; Rezagholizadeh F; Mahdiannasser M; Kazerani R; Modarressi MH
Heart Lung; 2021; 50(2):334-343. PubMed ID: 33524863
[TBL] [Abstract][Full Text] [Related]
12. Lox-1: the multifunctional receptor underlying cardiovascular dysfunction.
Ogura S; Kakino A; Sato Y; Fujita Y; Iwamoto S; Otsui K; Yoshimoto R; Sawamura T
Circ J; 2009 Nov; 73(11):1993-9. PubMed ID: 19801851
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization and expression analysis of novel alternative splicing isoforms of Olr1 gene during mouse embryogenesis.
Vecchione L; Diano L; Campagnolo L; Rocchi L; Ferrè F; Mehta JL; Novelli G; Amati F
Gene; 2012 Jan; 491(1):5-12. PubMed ID: 22001547
[TBL] [Abstract][Full Text] [Related]
14. Role of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicing.
Tejedor JR; Tilgner H; Iannone C; Guigó R; Valcárcel J
RNA; 2015 Jun; 21(6):1187-202. PubMed ID: 25904137
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome.
Palmieri VO; Coppola B; Grattagliano I; Casieri V; Cardinale G; Portincasa P; Palasciano G; Di Serio F
Eur J Clin Invest; 2013 Jan; 43(1):41-8. PubMed ID: 23134583
[TBL] [Abstract][Full Text] [Related]
16. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
[TBL] [Abstract][Full Text] [Related]
17. G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke.
Hattori H; Sonoda A; Sato H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Brain Res; 2006 Nov; 1121(1):246-9. PubMed ID: 17022953
[TBL] [Abstract][Full Text] [Related]
18. LOX-1 and atherosclerotic-related diseases.
Jin P; Cong S
Clin Chim Acta; 2019 Apr; 491():24-29. PubMed ID: 30639239
[TBL] [Abstract][Full Text] [Related]
19. LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.
Lubrano V; Balzan S; Papa A
Mol Cell Biochem; 2023 Oct; ():. PubMed ID: 37789136
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein.
Veas C; Jara C; Willis ND; Pérez-Contreras K; Gutierrez N; Toledo J; Fernandez P; Radojkovic C; Zuñiga FA; Escudero C; Aguayo C
J Cardiovasc Pharmacol; 2016 Apr; 67(4):326-35. PubMed ID: 26771151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
